Wrap Text
Dealings in securities by the company, by directors, by directors of major subsidiaries and by the company secretary
LIFE HEALTHCARE GROUP HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
(Registration number: 2003/002733/06)
ISIN: ZAE000145892
Share code: LHC
("Life Healthcare" or "the Company" or "the Group")
DEALINGS IN SECURITIES BY THE COMPANY, BY DIRECTORS, BY DIRECTORS OF MAJOR
SUBSIDIARIES AND BY THE COMPANY SECRETARY
Shareholders are referred to the Stock Exchange News Service announcement released on 15 December 2021
wherein the Company advised that, in response to the risk of losing key personnel stationed throughout the
Group, the board of directors of the Company approved the introduction of an additional long-term
incentive, the “Co-investment Policy” ("CIP"). This policy requires key personnel, including executives, to
invest in the Company’s securities in lieu of a portion of their bonus ("Bonus Shares") and the Company is
then required to match the Bonus Shares with the purchase of Life Healthcare shares ("the Company
Matched Shares") in favour of CIP participants. The Bonus Shares and Company Matched Shares will be
restricted and will vest in 2025, subject to specified performance conditions being achieved over the vesting
period.
In addition, CIP participants will be awarded Company Performance Shares, which will be restricted and will
vest in 2025, subject to specified performance conditions being achieved over the vesting period.
The required clearance has been given in terms of paragraph 3.66 of the JSE Listings Requirements.
Following the first four tranches of shares purchased by the Company on 9, 10, 13 and 14 December 2021,
the final tranche of shares has been purchased by Life Healthcare on 15 December 2021 in order to satisfy its
obligations under the CIP. Details of the final tranche of the purchase of shares are set out below:
Name of entity : Life Healthcare Group Holdings Limited
Nature of transaction : On market purchase of shares by the Company to satisfy its
obligations under the CIP
Date of transaction : 15 December 2021
Number of securities : 3 069 469
Class of securities : Ordinary shares
Total value of transaction : R72,749,177.82
VWAP per share : R23.70
Highest purchase price per share : R23.93
Lowest purchase price per share : R23.25
The following prescribed officers are beneficiaries under the CIP:
- Peter Wharton-Hood, Group Chief Executive Officer and executive director of Life Healthcare;
- Pieter van der Westhuizen, Group Chief Financial Officer and executive director of Life Healthcare;
- Adam Pyle, director of Life Healthcare Group Proprietary Limited, a major subsidiary of the Company;
- Megandra Naidoo, a director of Life Healthcare Group Proprietary Limited, a major subsidiary of the
Company;
- Craig Koekemoer, a director of Life Healthcare Group Proprietary Limited, a major subsidiary of the
Company;
- Kurt Wylie, a director of Life Healthcare Group Proprietary Limited, a major subsidiary of the
Company;
- Mark Chapman, a director of Alliance Medical Group Limited, a major subsidiary of the Company;
- Howard Marsh, a director of Alliance Medical Group Limited, a major subsidiary of the Company; and
- Joshila Ranchhod, the Company Secretary of Life Healthcare;
(collectively "the executive participants") who accepted the value of the monetary awards on the dates set
out below. The shares were then allocated to the executive participants on 15 December 2021, once the final
tranche of shares was purchased. The shares were allocated to each of the executive participants in
accordance with the extent of their investment in Bonus Shares in terms of the CIP, the details which are set
out below:
Shares
Date of Executive
acceptance of investment Company Company
monetary (Bonus Matched Performance
Executive award Shares) Shares Shares Total Shares
P Wharton-Hood 6 Dec 2021 198 238 594 714 265 497 1 058 449
P van der Westhuizen 6 Dec 2021 114 641 343 923 188 969 647 533
A Pyle 7 Dec 2021 80 476 241 428 149 955 471 859
M Naidoo 7 Dec 2021 43 324 129 972 109 220 282 516
C Koekemoer 8 Dec 2021 35 166 105 498 88 654 229 318
K wylie 6 Dec 2021 33 761 101 284 85 113 220 158
M Chapman 6 Dec 2021 108 334 325 003 201 865 635 202
H Marsh 6 Dec 2021 54 450 163 349 137 268 355 067
J Ranchhod 7 Dec 2021 32 399 97 196 81 678 211 273
Total 700 789 2 102 367 1 308 219 4 111 375
The nature and extent of each of the executive participants’ interest in the transactions is direct and beneficial.
Dunkeld
20 December 2021
Sponsor
RAND MERCHANT BANK (A division of FirstRand Bank Limited)
Date: 20-12-2021 03:30:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Sharenet Sites 
